跳至主要内容
临床试验/NCT00252369
NCT00252369终止不适用

Instillation of Fibrin Glue After Induction of Local Conditions Using Infliximab, in the Treatment of Perianal Crohn's Disease.

Sheba Medical Center5 个研究点 分布在 1 个国家开始时间: 2005年11月11日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
终止
试验地点
5
主要终点
Fistula healing

研究概览

简要总结

This study is aimed to assess the hypothesis that instillation of fibrin glue with the induction of local conditions using Infliximab, may be useful in the treatment of perianal Crohn's disease.

详细描述

Patients with perianal fistulae of Crohn's disease will be prospectively enrolled and receive 3 doses of Infliximab. If reduction of fistula associated discharge of at least 50% will be recorded, commercially available fibrin glue will be instilled into the fistula tract using standard surgical techniques. The patients will be followed for 6 months for fistula healing and complications.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Perianal fistula of Crohn's dis

排除标准

  • More then 2 fistulae perianal sepsis known contraindication to infliximab or glue

结局指标

主要结局

Fistula healing

次要结局

  • Quality of life
  • Complications

研究者

申办方类型
Other Gov

研究点 (5)

Loading locations...

相似试验